Anti-CD4 antibodies are associated with a specific decrease in CD4-positive lymphocytes in HIV-1 seroconverters. The Multicenter AIDS Cohort Study (MACS). NLM AIDSLINE Important note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Anti-CD4 antibodies are associated with a specific decrease in CD4-positive lymphocytes in HIV-1 seroconverters. The Multicenter AIDS Cohort Study (MACS).

Abstr Gen Meet Am Soc Microbiol. 1993;93:435 (abstract no. T-22). Unique Identifier : AIDSLINE ASM93/93291817
Keay S; Wecksler W; Wasserman SS; Department of Veterans Affairs Medical Center, Baltimore, MD.


Abstract: We previously showed that anti-CD4 antibodies may be present in up to 85% of persons at the time of HIV-1 seroconversion, the timing of which response suggests that these anti-CD4 antibodies are generated as anti-idiotype antibodies against anti-gp 120/160 antibodies made in response to HIV-1 infection. Such anti-idiotype anti-CD4 antibodies were previously shown by us and others to be generated in response to HIV-1 infection or rgp 160 immunization. The significance of these antibodies regarding the development of the acquired immunodeficiency syndrome is unknown. 161 serum specimens obtained from 31 HIV-1 infected persons at six month intervals surrounding the time of HIV-1 seroconversion were tested for anti-CD4 activity by ELISA and Western blot, and the results compared to total CD4-positive and CD8-positive cell counts obtained at the same time points. Anti-CD4 antibodies were detectable at the time of HIV-1 seroconversion in 83% of these persons by ELISA, and 76% by Western blot. For each of 18 persons for whom CD4-positive and CD8-positive cell counts were available at the appropriate time points, a greater drop in CD4-positive cell counts occurred during the six months immediately preceding the detection of anti-CD4 antibodies than in the previous six months during which anti-CD4 antibodies were not detected (Sign test, n = 18, p = 0.008). These same persons did not have a drop in CD8-positive cell count during this time (p = 0.81). These results confirm our earlier findings that anti-CD4 antibodies are frequently present in the sera of HIV-1 infected persons at the time of HIV-1 seroconversion, and show that the appearance of these antibodies is correlated with a specific decrease in CD4-positive cell counts, suggesting that they may play a role in the pathogenesis of HIV-1 infection.
Keywords: Acquired Immunodeficiency Syndrome/BLOOD/*IMMUNOLOGY Antibodies, Anti-Idiotypic/*BLOOD Antibody Formation Antigens, CD4/*IMMUNOLOGY Blotting, Western Enzyme-Linked Immunosorbent Assay Gene Products, env/IMMUNOLOGY Human HIV Antibodies/BLOOD HIV Envelope Protein gp120/IMMUNOLOGY HIV Seropositivity/BLOOD/*IMMUNOLOGY *HIV-1 Protein Precursors/IMMUNOLOGY Recombinant Proteins/IMMUNOLOGY T-Lymphocyte Subsets/*IMMUNOLOGY ABSTRACTKWDacquiredimmunodeficiencysyndrome/blood/KWDimmunologyantibodies,anti-idiotypic/KWDbloodantibodyformationantigens,cd4/KWDimmunologyblotting,westernenzyme-linkedimmunosorbentassaygeneproducts,env/immunologyhumanhivantibodies/bloodhivenvelopeproteingp120/immunologyhivseropositivity/blood/KWDimmunologyKWDhiv-1proteinprecursors/immunologyrecombinantproteins/immunologyt-lymphocytesubsets/KWDimmunologyabstract
930930
M9391154

Copyright © 1993 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .